Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors

Ruichao Chai,Songyuan An,Han Lin,Bo Pang,Hao Yan,Yun Liu,Yilin Wu,Long Wang,Xing Liu,Huiyuan Chen,Xueyu Yang,Qing Chang,Wenqing Jia,Yongzhi Wang

DOI: https://doi.org/10.1038/s41698-024-00541-w

2024-02-22

npj Precision Oncology

Abstract:Abstract Pre-surgery differential diagnosis is valuable for personalized treatment planning in intramedullary spinal cord tumors. This study assessed the performance of sequencing cell-free DNA (cfDNA) in cerebrospinal fluid (CSF) for differential diagnosis of these tumors. Prospectively enrolling 45 patients with intramedullary spinal cord lesions, including diffuse midline glioma (DMG), H3K27-altered (14/45), glioblastoma (1/45), H3-wildtype-astrocytoma (10/45), ependymoma (11/45), and other lesions (9/45), CSF samples were collected via lumbar puncture (41/45), intraoperative extraction (3/45), and Ommaya reservoir (1/45). Then, these samples underwent targeted sequencing along with paired tissue DNA. DMG, H3K27-altered patients exhibited a higher ctDNA positivity (85.7%, 12/14) compared to patients with H3-wildtype-astrocytoma (0/8, P = 0.0003), ependymoma (2/10, P = 0.003), and glioneuronal tumor (0/3, P = 0.009). The histological-grade-IV ( P = 0.0027), Ki-67 index ≥10% ( P = 0.014), and tumor reaching spinal cord surface ( P = 0.012) are also associated with higher ctDNA positivity. Interestingly, for patients with TERT promoter mutant tumors, TERT mutation was detectable in the CSF cfDNA of one DMG case, but not other five cases with histological-grade-II tumors. Shared copy number variants were exclusively observed in DMG, H3K27-altered, and showed a strong correlation (Correlation = 0.95) between CSF and tissue. Finally, H3K27M mutations in CSF exhibited high diagnostic efficiency for DMG, H3K27-altered (Sensitivity = 85.7%, Specificity = 100.0%, AUC = 0.929). Notably, H3K27M was detectable in CSF from patients with recurrent tumors, making it easily applicable for postoperative monitoring. In conclusion, the molecular profile from ctDNA released into CSF of malignant tumors was more frequently detected compared to relatively benign ones. Sequencing of ctDNA in CSF exhibited high efficiency for the differential diagnosis of DMG, H3K27-altered.

oncology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to achieve early differential diagnosis of intramedullary spinal cord tumors by detecting cell - free DNA (cfDNA) in cerebrospinal fluid (CSF), especially for the differential diagnosis of diffuse midline glioma (DMG) and H3K27 - altered tumors. Specifically, the study aims to evaluate the performance of CSF cfDNA sequencing in the preoperative differential diagnosis of intramedullary spinal cord tumors, so as to assist in the formulation of personalized treatment plans, reduce the risk of invasive surgery, and improve the accuracy of diagnosis.

### Research Background
Intramedullary spinal cord tumors show significant heterogeneity, and different pathological classifications lead to obvious differences in survival time. Currently, patients usually need to undergo biopsy or combined with resection surgery for pathological diagnosis after imaging examinations. However, due to the high sensitivity and functionality of the spinal cord, invasive operations such as biopsy or surgery may damage nerve functions, and the surgical risk of intramedullary tumors is higher than that of extramedullary tumors. Therefore, non - invasive preoperative differential diagnosis methods are crucial for formulating personalized treatment regimens.

### Research Methods
The study prospectively included 45 patients with intramedullary spinal cord lesions and collected their CSF samples, which were obtained by lumbar puncture (41/45), intraoperative extraction (3/45) or Ommaya reservoir (1/45). Subsequently, these samples were subjected to targeted sequencing, and the paired tissue DNA was also sequenced. The target genomes for sequencing included 131 genes.

### Main Findings
1. **ctDNA Positive Rate**:
- The ctDNA positive rate in patients with DMG and H3K27 - altered types was significantly higher than that in patients with H3 wild - type astrocytoma, ependymoma and other lesions.
- High - level histological grading (grade IV), Ki - 67 index ≥ 10% and tumors reaching the spinal cord surface were associated with a higher ctDNA positive rate.

2. **Mutation Consistency**:
- Shared mutations between CSF and tissue samples were more common in patients with DMG and H3K27 - altered types.
- Shared copy number variations (CNVs) mainly occurred in patients with DMG and H3K27 - altered types, and the CNV values between CSF and tissue samples were highly consistent (correlation coefficient = 0.95).

3. **Diagnostic Efficiency of H3K27M Mutation**:
- The detection of H3K27M mutation in CSF had high sensitivity (85.7%) and specificity (100%), with an AUC value of 0.929, which was suitable for the differential diagnosis of DMG and H3K27 - altered types.
- The H3K27M mutation could also be detected in the CSF of recurrent tumors, indicating its potential application value in postoperative monitoring.

### Conclusion
This study shows that CSF cfDNA sequencing has high efficiency in the preoperative differential diagnosis of intramedullary spinal cord tumors, especially for DMG and H3K27 - altered type tumors. In addition, the detection of H3K27M mutation in CSF not only helps preoperative diagnosis but may also be used for postoperative monitoring of tumor recurrence. However, for H3 wild - type astrocytoma and ependymoma, challenges still exist in CSF cfDNA detection, and further research is needed to optimize the detection method.